To ensure the specificity of the identified signals and enhance potential causal relevance, we restricted our inclusion to reports where PD-1/PD-L1 inhibitors were identified as the Primary Suspected (PS) drug
All medications come from licensed 503A compounding pharmacies, ensuring quality at accessible pricing
Finally, we saw clear variation in ETD by subgroups, including by demographic and clinical features
JAMA 325(14):14031413 Rubino D, Abrahamsson N, Davies M et al (2021) Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial
In support of this, circulating expression of glutathione peroxidase in the prostate tissue and plasma are markedly reduced in patients with prostate cancer
This combination of enhanced fat oxidation, decreased fat absorption, and improved insulin sensitivity underscores EGCGs potential as a natural and effective agent in combating obesity